SCHEMBL26423458

SCHEMBL26423458

c1cnc2nc3c(nc2c1)oc1cnccc13

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.37
TDO2 P48775 1/20 0.35
ALDH1A1 P00352 4/20 0.33
HSD17B10 Q99714 3/20 0.33
IDO1 P14902 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
KDM4E B2RXH2 5/20 0.33
HPGD P15428 2/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
BRAF P15056 5/20 0.32
EIF2AK3 Q9NZJ5 5/20 0.32
F7 P08709 2/20 0.32
F3 P13726 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26423464 0.94 MAPK14 (0.37) MAPK14TDO2ALDH1A1HSD17B10IDO1
SCHEMBL26423470 0.90 MAPK14 (0.38) MAPK14ALDH1A1HSD17B10IDO1MEN1
SCHEMBL26423462 0.84 MAPK14 (0.38) MAPK14ALDH1A1HSD17B10IDO1MEN1
SCHEMBL26423371 0.83 IDO1 (0.40) TDO2ALDH1A1HSD17B10IDO1MEN1
SCHEMBL26423461 0.77 IDO1 (0.34) TDO2ALDH1A1IDO1KDM4EF7
SCHEMBL26423479 0.77 KDM4E (0.39) MAPK14ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL26423449 0.77 KDM4E (0.39) MAPK14ALDH1A1HSD17B10KDM4EHPGD
SCHEMBL26423460 0.77 IDO1 (0.34) TDO2ALDH1A1IDO1KDM4EF7
SCHEMBL26423491 0.74 TDO2 (0.33) TDO2IDO1BRAFEIF2AK3
SCHEMBL26423372 0.72 ALDH1A1 (0.38) ALDH1A1HSD17B10IDO1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL OCIAD2, OCIAD1, AZI2 MAPK14 1074/4885TDO2 500/4885ALDH1A1 302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.